Phil Chamberlain
@neomorphinc
with the 1st disclosure at #AACR26: Unfortunately „do not post“ on all slides! A CRBN-hijacking molecular glue degrader of transcription factor ARNT with robust monotherapy efficacy for treatment of VHL loss ccRCC. Taking IMiDs beyond G loop targets.